Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Colorectal Neoplasms 8Polycythemia Vera 6Multiple Myeloma 5Prostatic Neoplasms 4Neoplasms 4Colonic Neoplasms 4Cardiovascular Diseases 4Venous Thromboembolism 3Thrombocythemia, Essential 3Precancerous Conditions 3Ovarian Neoplasms 3Neoplasms, Plasma Cell 3Myeloproliferative Disorders 3Melanoma 3Esophageal Neoplasms 3Barrett Esophagus 3Tobacco Use Disorder 2Thrombosis 2Thromboembolism 2Stomach Neoplasms 2Rectal Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Adenomatous Polyps 2Vascular Diseases 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stroke 1

Interventions

Photochemotherapy 2Biopsy 2Tobacco Products 1Sulindac 1Rosiglitazone 1Pioglitazone 1Nivolumab 1Gene Expression Profiling 1Fluconazole 1Ethanol 1Dihematoporphyrin Ether 1Dapsone 1Celecoxib 1Catechin 1Behavior Therapy 1Aspirin 1Acyclovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukoplakia, Oral × Aspirin × Clear all
NCT01238185 2013-08-12

Aspirin Mouthwash in Treating Patients With Oral Leukoplakia

National Cancer Institute (NCI)

Phase 1 Completed
40 enrolled
Head & NeckOther neoplasm

Leukoplakia, Oral, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡